These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

277 related items for PubMed ID: 21515295

  • 1. Maintenance on a high-fat diet impairs the anorexic response to glucagon-like-peptide-1 receptor activation.
    Williams DL, Hyvarinen N, Lilly N, Kay K, Dossat A, Parise E, Torregrossa AM.
    Physiol Behav; 2011 Jul 06; 103(5):557-64. PubMed ID: 21515295
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. The common hepatic branch of the vagus is not required to mediate the glycemic and food intake suppressive effects of glucagon-like-peptide-1.
    Hayes MR, Kanoski SE, De Jonghe BC, Leichner TM, Alhadeff AL, Fortin SM, Arnold M, Langhans W, Grill HJ.
    Am J Physiol Regul Integr Comp Physiol; 2011 Nov 06; 301(5):R1479-85. PubMed ID: 21849636
    [Abstract] [Full Text] [Related]

  • 5. Effect of glucagon-like peptide-1 receptor antagonism on appetite and food intake in healthy men.
    Steinert RE, Schirra J, Meyer-Gerspach AC, Kienle P, Fischer H, Schulte F, Goeke B, Beglinger C.
    Am J Clin Nutr; 2014 Aug 06; 100(2):514-23. PubMed ID: 24965303
    [Abstract] [Full Text] [Related]

  • 6. Combination of obesity and high-fat feeding diminishes sensitivity to GLP-1R agonist exendin-4.
    Duca FA, Sakar Y, Covasa M.
    Diabetes; 2013 Jul 06; 62(7):2410-5. PubMed ID: 23423571
    [Abstract] [Full Text] [Related]

  • 7. Endogenous hindbrain glucagon-like peptide-1 receptor activation contributes to the control of food intake by mediating gastric satiation signaling.
    Hayes MR, Bradley L, Grill HJ.
    Endocrinology; 2009 Jun 06; 150(6):2654-9. PubMed ID: 19264875
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Comparative effects of the long-acting GLP-1 receptor ligands, liraglutide and exendin-4, on food intake and body weight suppression in rats.
    Hayes MR, Kanoski SE, Alhadeff AL, Grill HJ.
    Obesity (Silver Spring); 2011 Jul 06; 19(7):1342-9. PubMed ID: 21415845
    [Abstract] [Full Text] [Related]

  • 10. Separation of emetic and anorexic responses of exendin-4, a GLP-1 receptor agonist in Suncus murinus (house musk shrew).
    Chan SW, Lin G, Yew DT, Yeung CK, Rudd JA.
    Neuropharmacology; 2013 Jul 06; 70():141-7. PubMed ID: 23357334
    [Abstract] [Full Text] [Related]

  • 11. A glucagon-like peptide-1 receptor agonist and an antagonist modify macronutrient selection by rats.
    Peters CT, Choi YH, Brubaker PL, Anderson GH.
    J Nutr; 2001 Aug 06; 131(8):2164-70. PubMed ID: 11481412
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Glucagon-like peptide 1 receptors in nucleus accumbens affect food intake.
    Dossat AM, Lilly N, Kay K, Williams DL.
    J Neurosci; 2011 Oct 12; 31(41):14453-7. PubMed ID: 21994361
    [Abstract] [Full Text] [Related]

  • 14. Combined stimulation of glucagon-like peptide-1 receptor and inhibition of cannabinoid CB1 receptor act synergistically to reduce food intake and body weight in the rat.
    Bojanowska E, Radziszewska E.
    J Physiol Pharmacol; 2011 Aug 12; 62(4):395-402. PubMed ID: 22100840
    [Abstract] [Full Text] [Related]

  • 15. Oxyntomodulin and glucagon-like peptide-1 differentially regulate murine food intake and energy expenditure.
    Baggio LL, Huang Q, Brown TJ, Drucker DJ.
    Gastroenterology; 2004 Aug 12; 127(2):546-58. PubMed ID: 15300587
    [Abstract] [Full Text] [Related]

  • 16. Anorexic effects of intra-VTA leptin are similar in low-fat and high-fat-fed rats but attenuated in a subgroup of high-fat-fed obese rats.
    Bruijnzeel AW, Qi X, Corrie LW.
    Pharmacol Biochem Behav; 2013 Jan 12; 103(3):573-81. PubMed ID: 23107643
    [Abstract] [Full Text] [Related]

  • 17. Effects of glucagon-like peptide-1 receptor stimulation and blockade on food consumption and body weight in rats treated with a cannabinoid CB1 receptor agonist WIN 55,212-2.
    Radziszewska E, Bojanowska E.
    Med Sci Monit Basic Res; 2013 Jan 01; 19():6-11. PubMed ID: 23291632
    [Abstract] [Full Text] [Related]

  • 18. The glucagon-like peptide 1 (GLP-1) analogue, exendin-4, decreases the rewarding value of food: a new role for mesolimbic GLP-1 receptors.
    Dickson SL, Shirazi RH, Hansson C, Bergquist F, Nissbrandt H, Skibicka KP.
    J Neurosci; 2012 Apr 04; 32(14):4812-20. PubMed ID: 22492036
    [Abstract] [Full Text] [Related]

  • 19. Nucleus accumbens GLP-1 receptors influence meal size and palatability.
    Dossat AM, Diaz R, Gallo L, Panagos A, Kay K, Williams DL.
    Am J Physiol Endocrinol Metab; 2013 Jun 15; 304(12):E1314-20. PubMed ID: 23612998
    [Abstract] [Full Text] [Related]

  • 20. The food intake-suppressive effects of glucagon-like peptide-1 receptor signaling in the ventral tegmental area are mediated by AMPA/kainate receptors.
    Mietlicki-Baase EG, Ortinski PI, Rupprecht LE, Olivos DR, Alhadeff AL, Pierce RC, Hayes MR.
    Am J Physiol Endocrinol Metab; 2013 Dec 01; 305(11):E1367-74. PubMed ID: 24105414
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.